• Medicare Part B Spending and Anti-VEGF Drugs

    Written By: Jean Shaw
    Selected By: Andrew P. Schachat, MD

    Patel set out to tally the annual Medicare Part B costs associated with anti–vascular endothelial growth factor medications used by ophthalmologists.